Clinical Trial Update: The REACTplusNMES Trial: A Double-blinded RCT [NA]

View source ↗

Summary

The REACTplusNMES trial, a double-blind randomized controlled trial evaluating neuromuscular electrical stimulation for stroke, is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebrovascular Disease
• Hemorrhagic Stroke
• Stroke

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Stroke, Ischemic, Stroke Hemorrhagic | NA | Status: RECRUITING